We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Clinical Diagnostic Test Identifies Range of Mitochondrial Disorders

By LabMedica International staff writers
Posted on 09 Nov 2009
Print article
Image: Colored transmission electron micrograph (TEM) of a section through the membrane of a human cell showing two mitochondria (Photo courtesy of BSIP Meullemiestre / SPL).
Image: Colored transmission electron micrograph (TEM) of a section through the membrane of a human cell showing two mitochondria (Photo courtesy of BSIP Meullemiestre / SPL).
A clinical diagnostic test has been developed for the early identification of a wide range of mitochondrial disorders.

Mutations to one of the mitochondrial genes, or to a number of nuclear genes with roles in mitochondrial function, can cause diseases, which have very similar symptoms, making them difficult to diagnose and treat.

Scientists at the Seattle Children's Research Institute (WA, USA) and the Genome Sciences and Pediatrics Departments of the University of Washington (Seattle, WA, USA) created a molecular diagnostic tool that uses targeted genetic sequencing to screen patient's DNA for variations in 362 genes that have been associated with mitochondrial disease or mitochondrial function.

Scientists tested the tool by using it to screen three DNA samples. They found that the new method was able to accurately identify the mutation underlying each patient's condition. The large number of candidate genes examined is likely to increase sensitivity for identifying previously unknown genes responsible for mitochondrial disorders.

"Early and effective diagnosis [of mitochondrial disorders] is crucial for permitting appropriate management and accurate counseling," said scientists Jay Shendure and Sihoun Hahn. "Mitochondrial diseases affect as many as 1 in 5,000 children; however diagnosis is notoriously difficult due to the huge number of genes potentially responsible for these disorders. For these reasons, some patients may remain undiagnosed and even die of untreated disease" according to Dr. Hahn. He added, "Our study indicates that the use of next generation sequencing technology holds great promise as a tool for screening mitochondrial disorders."

The study was published in the journal Genome Medicine on October 23, 2009.

Related Links:

Seattle Children's Research Institute
Department of Pediatrics of the University of Washington School of Medicine



New
Gold Member
Troponin T QC
Troponin T Quality Control
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
C-Reactive Protein Test
mLabs CRP
New
Dengue Test
Lab Rapid Dengue NS1

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The Accelerate Arc System has been granted US FDA 510(k) clearance (Photo courtesy of Accelerate Diagnostics)

Automated Positive Blood Culture Sample Preparation Platform Designed to Fight Against Sepsis and AMR

Delayed administration of antibiotics to patients with bloodstream infections significantly increases the risk of morbidity and mortality. For optimal therapeutic outcomes, it is crucial to rapidly identify... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.